Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2018

Feb 26, 2018

32337_dirs_2018-02-26_6bcaa476-4cbc-4df5-be33-2c681638ced9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2018-02-22

Reporting Person: Lamberti Frank (EVP, Dist/Customer Experience)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-26 Common Stock A 1882 $0.00 Acquired 11164 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-22 Stock Appreciation Rights $30.44 A 8442 Acquired 2025-03-02 Common Stock (8442) Direct
2018-02-22 Stock Appreciation Rights $54.75 A 1567 Acquired 2026-02-28 Common Stock (1567) Direct
2018-02-22 Stock Appreciation Rights $62.51 A 3359 Acquired 2026-05-09 Common Stock (3359) Direct
2018-02-22 Stock Appreciation Rights $57.19 A 3531 Acquired 2027-02-27 Common Stock (3531) Direct

Footnotes

F1: Consists of restricted stock units ("RSU") under the Herbalife Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 20% each on February 26, 2019 and February 26, 2020, and 60% on February 26, 2021.

F2: On March 2, 2015, the reporting person was granted an award of 14,070 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 8,442 which will vest on March 2, 2018.

F3: On February 28,2016, the reporting person was granted an award of 7,837 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 1,567 SARs which will vest on February 28, 2018.

F4: On May 9, 2016, the reporting person was granted an award of 16,795 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 3,359 SARs which will vest on May 9, 2018.

F5: On February 27, 2017, the reporting person was granted an award of 17,655 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 3,531 SARs which will vest on February 27, 2018.